This paper argues that there is a need to increase the involvement of Australian general practitioners (GPs) working in private practice to realise the potential of direct-acting antiviral treatments for people with the hepatitis C virus.

This paper, produced by ACON, combines the expertise from staff who operate ACON’s needle and syringe programs with current research to provide seven policy recommendations that will innovate such programs.

This cross-sectional study aimed to determine treatment rates among those newly diagnosed with the hepatitis C virus (HCV) virus in the South Western Sydney Local Health District (SWSLHD) in NSW, Australia.

This publication features diverse case studies of activity and innovation happening in the New Zealand public health sector.

This report finds that global harm reduction response has effectively stalled. Overdose, HIV and Hepatitis C crises continue, among a myriad of other health and social problems related to drug use and drug policy.